GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE
Revista Alergia México · 15.06.2019 · 66 (sup 1) · 1-105
DOI: 10.29262/ram.v66i5.631 ↗Kurz gefasst
Leitlinie in der Zeitschrift Revista Alergia México, online erschienen am 15.06.2019. Verfasst von Désirée Larenas-Linnemann und 56 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Clínica y Hospital Médica Sur, Ciudad de México. marlar1@prodigy.net.mx. Hauptthemen laut MEDLINE: Immunoglobulin E. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
In Mexico, allergen immunotherapy (AIT) and immunotherapy with hymenoptera venom (VIT) is traditionally practiced combining aspects of the European and American school. In addition, both types of extracts (European and American) are commercially available in Mexico. Moreover, for an adequate AIT/VIT a timely diagnosis is crucial. Therefore, there is a need for a widely accepted, up-to-date national immunotherapy guideline that covers diagnostic issues, indications, dosage, mechanisms, adverse effects and future expectations of AIT (GUIMIT 2019).
Method
With nationwide groups of allergists participating, including delegates from postgraduate training-programs in Allergy/Immunology-forming, the guideline document was developed according to the ADAPTE methodology: the immunotherapy guidelines from European Academy of Allergy and Clinical Immunology, German Society for Allergology and Clinical Immunology, The American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma, and Immunology were selected as mother guidelines, as they received the highest AGREE-II score among international guidelines available; their evidence conforms the scientific basis for this document.
Results
GUIMIT emanates strong or weak (suggestions) recommendations about practical issues directly related to in vivo or in vitro diagnosis of IgE mediated allergic diseases and the preparation and application of AIT/VIT and its adverse effects. GUIMIT finishes with a perspective on AIT modalities for the future. All the statements were discussed and voted on until > 80 % consensus was reached.
Conclusion
A wide and diverse group of AIT/VIT experts issued transculturized, evidence-based recommendations and reached consensus that might improve and standardize AIT practice in Mexico.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fundación Clínica y Hospital Médica Sur, Ciudad de México. marlar1@prodigy.net.mx.
Zitieren
APA
Larenas-Linnemann, D., Luna-Pech, J. A., Rodríguez-Pérez, N., Rodríguez-González, M., Arias-Cruz, A., Blandón-Vijil, M. V., Costa-Domínguez, M. C., Del Río-Navarro, B. E., Estrada-Cardona, A., Navarrete-Rodríguez, E. M., Ortega-Martell, J. A., Pozo-Beltrán, C. F., Brito-Díaz, H., Canseco-Raymundo, M. R., Castelán-Chávez, E. E., Domínguez-Silva, M. G., Escalante-Domínguez, A. J., Gálvez-Romero, J. L., García-Reyes, M. G., …, & Medina-Ávalos, M. A. (2019). GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE. Revista Alergia México, 66(sup 1), 1-105. https://doi.org/10.29262/ram.v66i5.631
Vancouver
Larenas-Linnemann D, Luna-Pech JA, Rodríguez-Pérez N, Rodríguez-González M, Arias-Cruz A, Blandón-Vijil MV, et al. GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE. Revista Alergia México. 2019;66(sup 1):1-105. doi:10.29262/ram.v66i5.631
BibTeX
@article{LarenasLinnemann2019,
author = {Larenas-Linnemann, Désirée and Luna-Pech, Jorge A and Rodríguez-Pérez, Noel and Rodríguez-González, Mónica and Arias-Cruz, Alfredo and Blandón-Vijil, María Virginia and Costa-Domínguez, María Carmen and Del Río-Navarro, Blanca E and Estrada-Cardona, Alan and Navarrete-Rodríguez, Elsy Maureen and Ortega-Martell, José Antonio and Pozo-Beltrán, César Fireth and Brito-Díaz, Herson and Canseco-Raymundo, María Rosario and Castelán-Chávez, Enrique Emanuel and Domínguez-Silva, Margarita Gabriela and Escalante-Domínguez, Alberto José and Gálvez-Romero, José Luis and García-Reyes, María Guadalupe and Gómez-Vera, Javier and González-Díaz, Sandra Nora and Guerrero-Núñez, María Gracias Belinda and Hernández-Colín, Dante and Macías-Weinmann, Alejandra and Mendoza-Hernández, David Alejandro and Meneses-Sánchez, Néstor Alejandro and Mogica-Martínez, María Dolores and Moncayo-Coello, Carol Vivian and Montiel-Herrera, Manuel and O'Farril-Romanillos, Patricia and Onuma-Takane, Ernesto and Ortega-Cisneros, Margarita and Rangel-Garza, Lorena and Stone-Aguilar, Héctor and Torres-Lozano, Carlos and Venegas-Montoya, Edna and Wakida-Kusunoki, Guillermo and Macouzet-Sánchez, Carlos and Partida-Gaytán, Armando and López-García, Aída Inés and Macías-Robles, Ana Paola and Ambriz-Moreno, María Jesús and Azamar-Jácome, Amyra Ali and Báez-Loyola, Carlos and Beltrán-De Paz, Claudia Yusdivia and Caballero-López, Chrystopherson and Fernández de Córdova-Aguirre, Juan Carlos and Fernández-Soto, Roberto and Lozano-Sáenz, José Santos and Oyoqui-Flores, José Joel and Osorio-Escamilla, Roberto and Ramírez, Fernando and Rivero-Yeverino, Daniela and Orozco-Martínez, María Socorro and Rojo-Gutiérrez, María Isabel and Martínez, Eric and Medina-Ávalos, Miguel Alejandro},
title = {GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE},
journal = {Revista Alergia México},
year = {2019},
volume = {66},
number = {sup 1},
pages = {1--105},
doi = {10.29262/ram.v66i5.631}
}
EUVIMED